These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Retrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic post mortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018. Gundersen POM, Broecker S, Slørdal L, Spigset O, Josefsson M. Forensic Sci Int; 2020 Jun; 311():110274. PubMed ID: 32302877 [Abstract] [Full Text] [Related]
3. Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer. El Balkhi S, Chaslot M, Picard N, Dulaurent S, Delage M, Mathieu O, Saint-Marcoux F. Int J Legal Med; 2017 Jul; 131(4):979-988. PubMed ID: 28160051 [Abstract] [Full Text] [Related]
4. Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine. Lehmann S, Sczyslo A, Froch-Cortis J, Rothschild MA, Thevis M, Andresen-Streichert H, Mercer-Chalmers-Bender K. Forensic Sci Int; 2019 Oct; 303():109959. PubMed ID: 31546164 [Abstract] [Full Text] [Related]
14. Assessment of the Availability, Cost, and Motivations for Use over Time of the New Psychoactive Substances-Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam-in the UK. Abouchedid R, Gilks T, Dargan PI, Archer JRH, Wood DM. J Med Toxicol; 2018 Jun; 14(2):134-143. PubMed ID: 29671244 [Abstract] [Full Text] [Related]
15. Femoral blood concentrations of flualprazolam in 33 postmortem cases. Kriikku P, Rasanen I, Ojanperä I, Thelander G, Kronstrand R, Vikingsson S. Forensic Sci Int; 2020 Feb; 307():110101. PubMed ID: 31865266 [Abstract] [Full Text] [Related]